Coenzyme Q10 for Fatigue

Verdict: CoQ10 does not relieve general fatigue

For everyday tiredness, coenzyme Q10 has not been shown to work: high-quality evidence and major health authorities do not support it as an energy or anti-fatigue supplement. A narrow, confounded signal exists only in specific conditions like ME/CFS, which does not justify general use.

D 🔴 D Counter-Evidence Counter-Evidence

🔬Why this grade7-layer evidence engine

The strongest signals are condition-specific and shaky, not general. The most-cited positive trial in chronic fatigue syndrome (Castro-Marrero 2021, PMID 34444817, n=207) tested CoQ10 combined with NADH, so any benefit cannot be attributed to CoQ10 alone, and it was industry-funded. A 2022 meta-analysis (Tsai, PMID 36091835, 13 RCTs, n=1126) found only a small-to-moderate effect (Hedges' g -0.40) across a grab-bag of unrelated populations with substantial heterogeneity. A post-viral fatigue review (PMID 10779395) rested on open-label, underpowered data.

For the most rigorously studied scenario, exercise, the result is a biomarker-symptom dissociation. A 2024 meta-analysis (Sangsefidi, PMID 38479900, 28 RCTs, n=830) showed CoQ10 lowers muscle-damage and oxidative-stress markers (CK, LDH, MDA) but did NOT improve physical performance or subjective fatigue. Examine.com grades CoQ10 'D' for general fatigue.

Regulators and clinics reinforce the counter-evidence grade. The EU's EFSA rejected CoQ10 energy-metabolism claims, finding no established cause-and-effect relationship; the US FDA treats disease claims as unapproved 'new drugs'; and UK NICE guidance recommends only riboflavin, not CoQ10. Harvard Health states plainly it 'has not been shown to boost your energy,' and no professional society endorses it for fatigue. Hence a Tier D, counter-evidence verdict.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.44
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Counter-Evidence
Confidence
77%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.30
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L5 Clinical bodiesAuthoritative stance
0.45
L1 ExamineGlobal benchmark
0.50
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.44
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — | C→D 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

PMID: 34444817 隨機對照試驗 n = 207
Finding: CoQ10 + NADH significantly reduced cognitive fatigue (FIS-40 cognitive subscale) and overall fatigue impact (FIS-40 total) versus placebo, with improvements in HRQoL (SF-36) and sleep efficiency at 4 and 8 weeks. Note: combination intervention, so CoQ10-specific effect cannot be isolated.
⚠️ Industry-funded
View on PubMed
PMID: 36091835 統合分析 n = 1,126
Finding: CoQ10 supplementation produced a small-to-moderate statistically significant reduction in subjective fatigue scores versus placebo across heterogeneous fatigue populations. Heterogeneity was substantial; effect appears dose- and duration-dependent. Safety profile favorable (1 GI AE / 602 intervention participants).
Academic Effect size: [object Object]
View on PubMed
PMID: 38479900 統合分析 n = 830
Finding: CoQ10 significantly reduced biomarkers of exercise-induced muscle damage (CK moderate effect, LDH very large effect, myoglobin) and oxidative stress (MDA), but did NOT meaningfully improve physical performance outcomes or total antioxidant capacity. Each 100 mg/day increase correlated with greater muscle damage marker reduction. Findings limited by Asian population predominance.
Academic
View on PubMed
PMID: 10779395 隨機對照試驗 n = 234
Finding: Open-label CoQ10 400 mg/day + selenium for 8 weeks improved FAS-derived fatigue severity and global QoL versus baseline in ME/CFS; review concludes CoQ10 supplementation is plausibly beneficial as adjunct in mitochondrial-dysfunction-driven post-viral fatigue, but underpowered single-arm and small RCT designs limit causal inference.
Academic
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
not generally recognized as safe and effective for the referenced uses and therefore are considered "new drugs" source↗
L4b EU EFSA
Against
a cause and effect relationship has not been established between the consumption of coenzyme Q10 and the claimed effects source↗
L4c UK NHS
Cautious
Advise people with migraine that the food supplement riboflavin (400 mg once a day) may be effective in reducing migraine frequency and intensity for some people. source↗
L4d TW TFDA / 衛福部
Cautious
訂定「食品原料輔酵素Q10 (Coenzyme Q10)之使用限制及標示規定」 source↗
L5c Cleveland Clinic
Cautious
CoQ10 plays a role in energy production source↗
L5d Harvard Health
Cautious
has not been shown to boost your energy, cure any health conditions, or help you live longer source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-fatigue-INT-coenzyme-q10-001 繁體中文版 →